used in traditional Chinese, Ayurvedic, and Thai medication. Conolidine could represent the start of a brand new era of chronic discomfort management. It is currently currently being investigated for its results to the atypical chemokine receptor (ACK3). Within a rat product, it was identified that a competitor molecule binding to ACKR3 resulted in